Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
3d
ScienceAfrica on MSNBook Review: Advances in Plant Breeding Methods, StrategiesConventional and Contemporary Practices of Plant BreedingTopics: Plant Sciences, Agriculture, Genetics and GenomicsAuthors: ...
A biomaterial that can mimic certain behaviors within biological tissues could advance regenerative medicine, disease modeling, soft robotics and more, according to researchers.
Chinese AI startup DeepSeek’s sudden technological advances are causing a market swoon for some of the biggest names in Silicon Valley. Those same advances are also cheering countries still ...
The move reflects growing concerns over the People’s Republic of China’s (PRC) strategic efforts to advance its biotech capabilities, which could potentially be leveraged for military and ...
Biotech stocks are companies that use living organisms to make drugs and vaccines. Often, they merge cutting-edge technology with new findings in molecular science and virology to treat life ...
Lose yourself in the best space books out there as we round up the pick of the out-of-this-world reading material across an array of categories. We've rounded up the best space books currently ...
Tune Therapeutics, a Durham biotechnology startup co-founded by ... The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...
Nevertheless, confidence in Seattle’s biotech future remains strong, experts said, because of the advances in medicine by its researchers and companies. “The science and technology driving ...
Meta Platforms shares rose 2.3% after the company reported results that beat expectations, including a 21% increase in sales. The owner of Facebook and Instagram reported earnings per share of $8. ...
(RTTNews) - Fortress Biotech, Inc. (FBIO), a biopharmaceutical company, announced on Monday that the first patient has been dosed in its Phase 2 clinical trial to evaluate the Triplex vaccine in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results